Fulminant Evans Syndrome and Splenic Infarction As Initial Manifestations of Poems Syndrome with Monoclonal Kappa Light Chain Restriction: A Diagnostic and Therapeutic Challenge.
{"title":"Fulminant Evans Syndrome and Splenic Infarction As Initial Manifestations of Poems Syndrome with Monoclonal Kappa Light Chain Restriction: A Diagnostic and Therapeutic Challenge.","authors":"Mohamed Reda Belkhribchia, Jean-Michel Vallat, Taoufik Lahoucine, Aurore Danigo, Youssef Chaoui, Mounir Rhounimi, Khalil Chafi","doi":"10.12890/2026_006921","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Autoimmune cytopenias have been very rarely reported in conjunction with POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes syndrome). To the best of our knowledge, there is no reported case in the existing literature of an association of Evans syndrome with POEMS syndrome.</p><p><strong>Case description: </strong>A 55-year-old female patient, with a medical history of well-controlled dermatomyositis, developed fulminant autoimmune haemolytic anaemia with immune thrombocytopenic purpura, thus fulfilling the diagnosis of Evans syndrome. To control the disease, acute management required supportive measures in the intensive care unit, repeated transfusions of red blood cells and platelets, high- dose intravenous corticosteroids, a bolus of cyclophosphamide, and splenectomy. Three days post-splenectomy, the patient developed, subacutely, full-blown POEMS syndrome. Therefore, the diagnosis of coexisting secondary Evans syndrome and POEMS syndrome was made. Notably, the monoclonal kappa light chain restriction and multiple splenic infarctions were distinctive features in our patient. Due to procurement issues of lenalidomide, we opted for monthly parenteral cyclophosphamide and autologous stem cell transplantation was programmed.</p><p><strong>Conclusion: </strong>This case highlights that severe secondary Evans syndrome can coexist with POEMS syndrome, leading to challenges in diagnosis and management.</p><p><strong>Learning points: </strong>Severe secondary Evans syndrome can coexist with POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome.High doses of corticosteroids required for the acute management of Evans syndrome may artificially lower the genuine value of serum vascular endothelial growth factor in the context of associated POEMS syndrome.In atypical circumstances like in our case (associated Evans syndrome, kappa light chain restriction), the nerve biopsy is critical to exclude differential diagnoses and confirm typical characteristics of POEMS syndrome- related polyneuropathy.</p>","PeriodicalId":11908,"journal":{"name":"European journal of case reports in internal medicine","volume":"13 7","pages":"006921"},"PeriodicalIF":0.0000,"publicationDate":"2026-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13374827/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of case reports in internal medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12890/2026_006921","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Autoimmune cytopenias have been very rarely reported in conjunction with POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes syndrome). To the best of our knowledge, there is no reported case in the existing literature of an association of Evans syndrome with POEMS syndrome.
Case description: A 55-year-old female patient, with a medical history of well-controlled dermatomyositis, developed fulminant autoimmune haemolytic anaemia with immune thrombocytopenic purpura, thus fulfilling the diagnosis of Evans syndrome. To control the disease, acute management required supportive measures in the intensive care unit, repeated transfusions of red blood cells and platelets, high- dose intravenous corticosteroids, a bolus of cyclophosphamide, and splenectomy. Three days post-splenectomy, the patient developed, subacutely, full-blown POEMS syndrome. Therefore, the diagnosis of coexisting secondary Evans syndrome and POEMS syndrome was made. Notably, the monoclonal kappa light chain restriction and multiple splenic infarctions were distinctive features in our patient. Due to procurement issues of lenalidomide, we opted for monthly parenteral cyclophosphamide and autologous stem cell transplantation was programmed.
Conclusion: This case highlights that severe secondary Evans syndrome can coexist with POEMS syndrome, leading to challenges in diagnosis and management.
Learning points: Severe secondary Evans syndrome can coexist with POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome.High doses of corticosteroids required for the acute management of Evans syndrome may artificially lower the genuine value of serum vascular endothelial growth factor in the context of associated POEMS syndrome.In atypical circumstances like in our case (associated Evans syndrome, kappa light chain restriction), the nerve biopsy is critical to exclude differential diagnoses and confirm typical characteristics of POEMS syndrome- related polyneuropathy.
期刊介绍:
The European Journal of Case Reports in Internal Medicine is an official journal of the European Federation of Internal Medicine (EFIM), representing 35 national societies from 33 European countries. The Journal''s mission is to promote the best medical practice and innovation in the field of acute and general medicine. It also provides a forum for internal medicine doctors where they can share new approaches with the aim of improving diagnostic and clinical skills in this field. EJCRIM welcomes high-quality case reports describing unusual or complex cases that an internist may encounter in everyday practice. The cases should either demonstrate the appropriateness of a diagnostic/therapeutic approach, describe a new procedure or maneuver, or show unusual manifestations of a disease or unexpected reactions. The Journal only accepts and publishes those case reports whose learning points provide new insight and/or contribute to advancing medical knowledge both in terms of diagnostics and therapeutic approaches. Case reports of medical errors, therefore, are also welcome as long as they provide innovative measures on how to prevent them in the current practice (Instructive Errors). The Journal may also consider brief and reasoned reports on issues relevant to the practice of Internal Medicine, as well as Abstracts submitted to the scientific meetings of acknowledged medical societies.